Revvity Board Declares Quarterly Dividend
Revvity (NYSE:RVTY) Flaunts Strong Technical Breakout Setup Near 52-Week High
Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Revvity Launches "Signals for Startups" to Help Emerging Biotechs Build Scalable Digital Foundations from Day One
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy?
Revvity (RVTY) Joins Anthropic Directory To Bring Claude Into Signals Research Workflows
Revvity to Hold Earnings Call on Tuesday, August 4, 2026
Evercore ISI Group Maintains Outperform on Revvity, Raises Price Target to $125
What You Need to Know Ahead of Revvity’s Earnings Release
3 Reasons to Avoid RVTY and 1 Stock to Buy Instead
Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration
Bernstein Reinstates Market Perform on Revvity, Announces $115 Price Target
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
Revvity Launches Signals AI
Is Revvity Stock Underperforming the Nasdaq?
Revvity Inc (NYSE:RVTY) Shows Technical Breakout Setup with Perfect Score
Revvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Revvity (RVTY) Valuation Check After China Immunodiagnostics Exit Plan And Solid First Quarter Results
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.